NEW YORK, July 04, 2017 (GLOBE NEWSWIRE) -- According to a new market research report “Global Image Guided Surgery Devices Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insight by Device Type (CT, Ultrasound, MRI, X-Ray Fluoroscopy, Endoscopes, PET and SPECT), by Application (Neurology, Orthopedic Surgery, ENT Surgery, Oncology Surgery and Others)” published by P&S Market Research, the global image guided surgery devices market is expected to grow at a CAGR of 6.5%, during 2017 - 2023.
As per the findings of the research, the CT is the largest segment, based on device type, in the global image guided surgery devices market. CT is a non-invasive, accurate and fast diagnostic imaging test. It uses x-ray equipment to produce 3D images by taking series of images from different angles. Each image created during the CT procedure shows the bones, tissues and organs in a thin “slice” of the body.
Browse Report Description with TOC on Image Guided Surgery Devices Market: https://www.psmarketresearch.com/market-analysis/image-guided-surgery-devices-market
It provides cross-sectional images generated during the CT scan and can be reformatted in multiple planes. It is used for diagnosing skeletal abnormalities, blood clots, blood vessel aneurysm and cancer. Neurology has been the largest application area for image guided surgery devices, followed by orthopedic surgery, ENT surgery, oncology surgery and others.
Geographically, North America has been the largest market for image guided surgery devices, with the U.S. being the larger contributor to the regional market. Increasing prevalence of neurological disorders, rising geriatric population and adoption of technological advanced imaging techniques are some of the factors that have been driving the growth of the North America image guided surgery devices market. The U.K. has been the largest contributor to the European market for image guided surgery devices, followed by Germany and France. The market is expected to witness the fastest growth in Asia-Pacific, during 2017 - 2023, owing to increasing cases of cancer, arthritis, neurological disorders and rising geriatric population.
According to the International Agency for Research on Cancer (IARC), a specialized cancer agency of World Health Organization (WHO) that promotes cancer research, 12.7 million new patients were detected with cancer in 2008, globally, and the number is expected to reach 21.4 million by 2030. Additionally, according to WHO, in 2012, 8.2 million deaths took place globally due to cancer, out of which 1.6 million were due to lung cancer, while 745,000 deaths resulted from liver cancer and 400,000 deaths were an outcome of esophageal cancer.
Pre-Purchase Enquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=image-guided-surgery-devices-market
The increasing burden of chronic diseases is expected to result in higher death rates and additional economic cost. Thus, several developments have been taking place for efficient disease diagnosis and treatment, leading to high adoption rate of image guided surgery devices, globally.
Some of the key players in the global image guided surgery devices market include Siemens AG, GE Healthcare, Koninklijke Philips N.V., Canon Inc., Hitachi, Ltd., KARL STORZ GmbH & Co. KG., Medtronic, Inc., St. Jude Medical, Inc., Varian Medical Systems, Inc., Smith & Nephew plc, Integra LifeSciences Corporation and Zimmer Holdings, Inc.
Browse Related Research
Vascular Imaging Systems Market
Vascular imaging systems are used to diagnose diseases related to blood flow in the arteries and veins. Surgeons can diagnose plaque formation, blockages in the veins, weakening of arteries and veins, blood clots, and varicose veins with the use of these systems. The global vascular imaging systems market has been segmented on the basis of product, application and end user.
https://www.psmarketresearch.com/market-analysis/vascular-imaging-systems-market
Wearable Injectors Market
Based on type, the global wearable injectors market has been segmented into body-worn patch injector, off-body worn belt injector and bolus injector. The bolus injector segment, though introduced in 2016, is expected to witness the highest growth during the forecast period, owing to its ability to treat various diseases such as cancer, auto-immune disease, infectious disease, cardiovascular disease and blood disorder.
https://www.psmarketresearch.com/market-analysis/wearable-injectors-market
Needle-Free Diabetes Management Market
The global needle-free diabetes management market is expected to witness a CAGR of 17.8% during the forecast period, to reach $16,831.5 million by 2025. The increasing awareness regarding the safety issues associated with needles is the key growth driver for the global market. Among the different types of needle-free diabetes management devices, artificial pancreas market is expected to witness the fastest growth during the forecast period.
https://www.psmarketresearch.com/market-analysis/needle-free-diabetes-management-market
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agencies, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook